Reimbursement

If current drug pricing trends continue, cost-related non-adherence to therapy will result in the premature deaths of 112,000 Medicare beneficiaries per year.
 

Pharmacists must demonstrate value to achieve success when implementing new services and especially when establishing an entirely new practice.

Medicaid expansion has helped to increase annual checkups among low income individuals. 
 

The combination of COVID-19 with opioid-induced respiratory depression, especially in an elderly patient, could be deadly.

Trends and comfort levels have changed among consumers, pharmacies, and payers from 2019 to 2020 as it relates to pharmacist-provided services and value-based performance programs.

Throughout the pandemic, pharmacists have played a critical role in the COVID-19 response in several ways

For many years, employers, payers, and pharmacy benefit managers have been developing benefit designs to incentivize patients and providers to make cost-effective treatment decisions.

A kickback can arise if a pharmacy pays commissions to a 1099 independent contractor marketing representative who generates patients for the pharmacy who are covered by a federal health care program.

Financial distress and disruptions to work and social activities were significantly associated with depression and anxiety, as well as generally diminished psychological wellbeing.

In the years following the passage of the Affordable Care Act, early-stage cancer diagnosis increased while late-stage fell. 
 

For hospital pharmacies, the COVID-19 pandemic sparked an abrupt and intensive reevaluation of nearly every aspect of their operations.

State Medicaid programs and other providers will need to learn more about the age distribution of autism among adults enrolled in Medicaid, in order to better serve them.